Effect of acetate-free biofiltration and bicarbonate hemodialysis on neutrophil activation

American Journal of Kidney Diseases

Volumn 40, Issue 4, 2002, Pages 783-793

  Todeschini, Marta ^a,b,c   Macconi, Daniela ^a,b,c   Fernández, Nuria García ^a,b,c   Ghilardi, Marina ^a,b,c   Anabaya, Agostina ^a,b,c   Binda, Elena ^a,b,c   Morigi, Marina ^a,b,c   Cattaneo, Dario ^a,b,c   Perticucci, Elena ^a,b,c   Remuzzi, Giuseppe ^a,b,c   Noris, Marina ^a,b,c  

^a MARIO NEGRI INST PHARMACOL RES   (Italy)

^b OSPEDALI RIUNITI   (Italy)

^c UNIVERSITY CLINIC OF NAVARRA   (Spain)

Author keywords

Acetate free biofiltration (AFB); Bicarbonate hemodialysis (BHD); Interleukin 1 (IL 1 ); Neutrophils; Nitric oxide (NO); Reactive oxygen species

Indexed keywords

ACETIC ACID; BALANCED SALT SOLUTION; BICARBONATE; CYTOKINE; INTERLEUKIN 1BETA; NITRIC OXIDE; POLYACRYLONITRILE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE;

ADULT; AGED; ARTICLE; BIOFILTRATION; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; DOSE TIME EFFECT RELATION; ENDOTHELIUM CELL; FEMALE; HEMODIALYSIS; HUMAN; MALE; MONOCYTE; NEUTROPHIL CHEMOTAXIS; OBSERVATION; OXIDATION KINETICS; POLYMORPHONUCLEAR CELL; UMBILICAL VEIN; UREMIA;

EID: 0036789681     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/ajkd.2002.35690     Document Type: Article

References (51)

1. Lindner A, Charra B, Sherrard DJ, Scribner BH: Accelerated atherosclerosis in prolonged maintenance hemodialysis. N Engl J Med 290:697-701, 1974
2. Huysmans K, Lins RL, Daelemans R, Zachée P, De Broe ME: Hypertension and accelerated atherosclerosis in end stage renal disease. J Nephrol 11:185-195, 1998
3. Steinberg D: Role of oxidized LDL and antioxidants in atherosclerosis. Adv Exp Med Biol 369:39-48, 1995
4. Wratten ML, Tetta C, Ursini F, Sevanian A: Oxidant stress in hemodialysis: Prevention and treatment strategies. Kidney Int 50:S126-S132, 2000 (suppl 76)
5. Ceballons-Picot I, Witko-Sarsat V, Merad-Boudia M, et al: Glutathione antioxidant system as a marker of oxidative stress in chronic renal failure. Free Radic Biol Med 21:845-853, 1996
6. Witko-Sarsat V, Nguyen-Khoa T, Jungers P, Drueke TB, Descamps-Latscha B: Advanced oxidation protein products as a novel molecular basis of oxidative stress in uraemia. Nephrol Dial Transplant 14:S76-S78, 1999 (suppl 1)
7. Horl WH, Schaefer RM, Heidland A: Effect of different dialyzers on proteinases and proteinase inhibitors during hemodialysis. Am J Nephrol 5:320-326, 1985
8. Himmelfarb J, Lazarus JM, Hakim R: Reactive oxygen species production by monocytes and polymorphonuclear leukocytes during dialysis. Am J Kidney Dis 17:271-276, 1991
9. Mege JL, Olmer M, Purgus R, et al: Haemodialysis membranes modulate chronically the production of TNF-α, IL-1β, and IL-6. Nephrol Dial Transplant 6:868-875, 1991
10. Cristol JP, Canaud B, Rabesandratana H, Gaillard I, Serre A, Mion C: Enhancement of reactive oxygen species production and cell surface markers expression due to haemodialysis. Nephrol Dial Transplant 9:389-394, 1994
11. Kaupke CJ, Zhang J, Cesario T, Yousefi S, Akeel N, Vaziri ND: Effect of hemodialysis on leukocyte adhesion receptor expression. Am J Kidney Dis 27:244-252, 1996
12. Noris M, Benigni A, Boccardo P, et al: Enhanced nitric oxide synthesis in uremia: Implications for platelet dysfunction and dialysis hypotension. Kidney Int 44:445-450, 1993
13. Yokokawa K, Mankus R, Saklayen MG, et al: Increased nitric oxide production in patients with hypotension during hemodialysis. Ann Intern Med 123:35-37, 1995
14. Herbelin A, Nguyen AT, Zingraff J, Urena P, Descamps-Latscha B: Influence of uremia and hemodialysis on circulating interleukin-1 and tumor necrosis factor α. Kidney Int 37:116-125, 1990
15. Luger A, Kovarik J, Stummvoll HK, Urbanska A, Luger TA: Blood-membrane interaction in hemodialysis leads to increased cytokine production. Kidney Int 32:84-88, 1987
16. Haeffner-Cavaillon N, Cavaillon JM, Ciancioni C, Bacle F, Delons S, Kazatchkine MD: In vivo induction of interleukin-1 during hemodialysis. Kidney Int 35:1212-1218, 1989
17. Bingel M, Lonnemann G, Koch KM, Dinarello CA, Shaldon S: Enhancement of in-vitro human interleukin-1 production by sodium acetate. Lancet 1:14-16, 1987
18. Kanno K, Hirata Y, Imai T, Iwashina M, Marumo F: Regulation of inducible nitric oxide synthase gene by interleukin-1β in rat vascular endothelial cells. Am J Physiol 267:H2318-H2324, 1994
19. Iwashina M, Hirata Y, Imai T, Sato K, Marumo F: Molecular cloning of endothelial, inducible nitric oxide synthase gene from rat aortic endothelial cell. Eur J Biochem 237:668-673, 1996
20. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA: Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci U S A 87:1620-1624, 1990
21. Zucchelli P, Santoro A, Ferrari G, Spongano M: Acetate-free biofiltration: Hemodiafiltration with base-free dialysate. Blood Purif 8:14-22, 1990
22. Galli G, Panzetta G: Acetate free biofiltration (AFB): From theory to clinical results. Clin Nephrol 50:28-37, 1998
23. Eiselt J, Racet J, Opatrny K: The effect of hemodialysis and acetate-free biofiltration on anemia. Int J Artif Organs 23:173-180, 2000
24. Zucchelli P, Santoro A, Spongano M: Acetate-free biofiltration: Acidosis correction and cardiovascular stability. Contrib Nephrol 108:105-113, 1994
25. Leunissen KML, Kooman JP, Van Kuijk WHM, Van Hoof JP: Bicarbonate dialysis: A review and future perspectives. Semin Dial 7:186-191, 1994
26. Movilli E, Camerini C, Zein H, et al: A prospective comparison of bicarbonate dialysis, hemodiafiltration, and acetate-free biofiltration in the elderly. Am J Kidney Dis 27:541-547, 1996
27. Carozzi S, Nasini MG, Caviglia PM, Schelotto C, Santoni O, Atti M: Acetate-free biofiltration. Effects on peripheral blood monocyte activation and cytokine release. ASAIO J 38:52-54, 1992
28. Higuchi T, Kuno T, Takahashi S, Kanmatsuse K: Chronic effects of long-term acetate-free biofiltration on the production of interleukin-1β and interleukin-1 receptor antagonist by peripheral blood mononuclear cells. Am J Nephrol 17:428-434, 1997
29. Noris M, Todeschini M, Casiraghi F, et al: Effect of acetate, bicarbonate dialysis and acetate-free biofiltration on nitric oxide synthesis: Implications for dialysis hypotension. Am J Kidney Dis 32:115-124, 1998
30. Paccitti A, Lanfranco G, Atti M, Mangiarotti G, Segoloni GP, Vercellone A: Un modello computerizzato di similazione della dialisi senza acetato. Nefrol Dial Trapianto 489-490, 1990
31. Macconi D, Zanoli AF, Orisio S, et al: Methylprednisolone normalizes superoxide anion production by polymorphs from patients with ANCA-positive vasculitides. Kidney Int 44:215-220, 1993
32. Jaffe EA, Nach RL, Becker CG, Minik CR: Culture of human endothelial cells derived from umbilical veins. J Clin Invest 52:2745-2756, 1973
33. Kobayashi Y, Kubo H, Kinoshita T: Post-column derivatization system for the fluorimetric determination of guanidino compounds with ninhydrin by reversed-phase ion-pair high performance liquid chromatography. J Chromatogr 400:113-121, 1987
34. Kuwahara T, Markert M, Wauters JP: Neutrophil oxygen radical production by dialysis membranes. Nephrol Dial Transplant 3:661-665, 1988
35. Himmelfarb J, Ault KA, Holbrook D, Leeber DA, Hakim RM: Intradialytic granulocyte reactive oxygen species production: A prospective, crossover trial. J Am Soc Nephrol 4:178-186, 1993
36. Port FK, VanDeKerkhove KM, Kunkel SL, Kluger MJ: The role of dialysate in the stimulation of interleukin-1 production during clinical hemodialysis. Am J Kidney Dis 10:118-122, 1987
37. Lonnemann G, Behme TC, Lenzner B, et al: Permeability of dialyzer membranes to TNFα-inducing substances derived from water bacteria. Kidney Int 42:61-68, 1992
38. Pertosa G, Gesualdo L, Bottalico D, Schena FP: Endotoxins modulate chronically tumor necrosis factor alpha and interleukin 6 release by uraemic monocytes. Nephrol Dial Transplant 10:328-333, 1995
39. Ing BL, Gupta DK, Nawab ZM, Zhou FQ, Rahman MA, Daugirdas JT: Suppression of neutrophil superoxide production by conventional peritoneal dialysis solution. Int J Artif Organs 11:351-354, 1988
40. Manahan FJ, Ing BL, Chan JC, et al: Effects of bicarbonate-containing versus lactate-containing peritoneal dialysis solutions on superoxide production by human neutrophils. Artif Organs 13:495-497, 1989
41. Dobos GJ, Burger M, Kuhlmann J, Passlick-Deetjen J, Schollmeyer P, Bohler J: Improved cytosolic free calcium mobilization and superoxide production in bicarbonate-based peritoneal dialysis solution. Nephrol Dial Transplant 12:973-977, 1997
42. Epperlein MM, Nourooz-Zadeh J, Jayasena SD, Hothersall JS, Noronha-Dutra A, Neild GH: Nature and biological significance of free radicals generated during bicarbonate hemodialysis. J Am Soc Nephrol 9:457-463,1998
43. Boaz M, Green M, Fainauru M, Smetana S: Oxidative stress and cardiovascular disease in hemodialysis. Clin Nephrol 55:93-100, 2001
44. Galli F, Varga Z, Balla J, et al: Vitamin E, lipid profile, and peroxidation in hemodialysis patients. Kidney Int 59:S148-S154, 2001 (suppl 78)
45. Yukawa S, Hibino A, Maeda T, et al: Effect of alpha-tocopherol on in vitro and in vivo metabolism of low-density lipoproteins in hemodialysis patients. Nephrol Dial Transplant 10:1-3, 1995
46. Yalcin AS, Yurtkuran M, Dilek K, Kilinc A, Taga Y, Emerk K: The effect of vitamin E therapy on plasma and erythrocyte lipid peroxidation in chronic hemodialysis patients. Clin Chim Acta 185:109-112, 1989
47. Boaz M, Smetana S, Weinstein T, et al: Secondary prevention with antioxidants of cardiovascular disease in end stage renal disease (SPACE): Randomised placebo-controlled trial. Lancet 356:1213-1218, 2000
48. Kaysen GA: The microinflammatory state in uremia: Causes and potential consequences. J Am Soc Nephrol 12:1549-1557, 2001
49. Pereira BJG, Dinarello CA: Production of cytokines and cytokine inhibitory proteins in patients on dialysis. Nephrol Dial Transplant 9:S60-S71, 1994 (suppl 2)
50. Memoli B: Cytokine production in haemodialysis. Blood Purif 17:149-158, 1999
51. Amore A, Cirina P, Mitola S, et al: Acetate intolerance is mediated by enhanced synthesis of nitric oxide by endothelial cells. J Am Soc Nephrol 9:1431-1436, 1997